Lung cancer screening feasibility in Australia
| Autor: | Richard Slaughter, Ian A. Yang, Elizabeth McCaul, Kwun M. Fong, Linda Passmore, Paul Zimmerman, Morgan Windsor, Rayleen V. Bowman, Henry M. Marshall, Melanie Lau, Jane Crossin, John Ayres, S. Redmond, Steven C. Leong, Deborah Courtney |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Pulmonary and Respiratory Medicine
Male medicine.medical_specialty Lung Neoplasms Population Computed tomography Adenocarcinoma X ray computed Carcinoma Non-Small-Cell Lung Forced Expiratory Volume medicine Humans Intensive care medicine education Early Detection of Cancer Aged education.field_of_study medicine.diagnostic_test business.industry Task force Patient Selection Smoking Age Factors Australia False positivity Middle Aged Ct screening Physical therapy Carcinoma Squamous Cell Feasibility Studies National Lung Screening Trial Female business Tomography X-Ray Computed Lung cancer screening |
| Zdroj: | The European respiratory journal. 45(6) |
| ISSN: | 1399-3003 |
| Popis: | The National Lung Screening Trial (NLST) reported a 20% relative reduction in lung cancer-specific mortality using low-dose computed tomography (LDCT) screening [1]. US Preventative Services Task Force modelling [2] illustrates the potentially large benefits of screening, yet nationwide population-based screening has not been adopted. Controversial issues include high false positivity, and uncertain cost-effectiveness and relative applicability to different settings and countries [3–6]. The Queensland Lung Cancer Screening Study (QLCSS) is the first study to assess NLST screening protocol feasibility in Australia. Low-dose CT screening using the NLST protocol appears feasible in the Australian health setting |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|